A Chinese scientist reviewing laboratory equipment

Research news

This section contains news items that were not issued as a press release.

Wednesday, 31 October 2012
Alzheimer’s, cancer and rare disease research to benefit from landmark MRC-AstraZeneca compound collaboration The Medical Research Council (MRC) will today announce £7 million of funding for 15 research projects awarded through its groundbreaking collaboration with innovative pharmaceutical company AstraZeneca
Monday, 29 October 2012
AstraZeneca and Nobel Media bring Nobel Laureate First AstraZeneca Nobel Medicine Initiative event in Korea aims to inspire local students and scientists.
Tuesday, 16 October 2012
Charles River enters strategic partnership with AstraZeneca Leading Global CRO Partners with Global Biopharmaceutical Company to Accelerate Drug Development
Monday, 15 October 2012
AstraZeneca and Nobel Media present Nobel Laureate on China lecture tour University lectures aim to inspire next generation of Chinese scientists
Monday, 15 October 2012
Pharmaron forms strategic partnership with AstraZeneca to accelerate drug discovery Pharmaron announced a drug discovery partnership with AstraZeneca to support their global Innovative Medicines Units.
Wednesday, 26 September 2012
AstraZeneca collaborates with Roche Diagnostics to advance personalised healthcare across therapeutic areas AstraZeneca today announced it has entered into a collaboration agreement with Roche Diagnostics
Wednesday, 26 September 2012
Elsevier Business Intelligence (EBI) and BayHelix award four prizes to celebrate innovation in China at PharmAsia Summit Shanghai Elsevier Business Intelligence and the BayHelix Group announced today that they awarded four prizes to celebrate innovation in China.
Wednesday, 19 September 2012
Ten Pharmaceutical Companies Unite to Accelerate New Non-Profit Organization to Speed Pharmaceutical R&D
Monday, 10 September 2012
AstraZeneca and the Broad Institute Partner to advance discovery of antibacterial and antiviral agents London, UK and Cambridge, USA – AstraZeneca and the Broad Institute in Cambridge, Massachusetts today announce a collaboration to identify new chemical compounds targeting bacterial and viral infections that could speed the development of new antibacterial and antiviral drugs.
Thursday, 23 August 2012
First agreements concluded under WIPO Re:Search for  research on Neglected Tropical Diseases Research to develop treatments for neglected tropical diseases received a boost this week as AstraZeneca concluded agreements through WIPO Re:Search with iThemba Pharmaceuticals (South Africa), the University of California (U.S), and the University of Dundee (UK).